NOVEMBER 2023LIFE SCIENCES REVIEW 7European companies are at the forefront of promoting sustainability in Sanger sequencing, emphasising eco-friendly practices to minimise waste, energy use, and water consumption in genetic research. These firms are committed to ushering in an era of sustainability, evident through their investments in energy-efficient equipment and clean energy sources to lower carbon emissions. Moreover, they uphold a stringent waste disposal and recycling regime alongside technological innovations that ensure the safe handling of chemicals and plastics in sequencing processes.Simultaneously, these companies prioritise eco-friendly materials and adopt sustainable sourcing practices, markedly reducing their reliance on single-use plastics while exploring alternatives such as biodegradable materials. By actively engaging in international partnerships and knowledge-sharing initiatives, they contribute significantly to the global endeavour of lessening the environmental footprint associated with genetic research. Through these concerted efforts, European companies are aligning their operations with responsible environmental stewardship and are also propelling a broader transformation towards sustainability in the field of genetic research.In this issue of Life Sciences Review, we highlight the prominent Sanger sequencing service providers in Europe who have been instrumental in driving scientific progress and remain essential across diverse research domains. One such featured company is Macrogen Europe, dedicated to expediting genomics breakthroughs. The convergence of advanced technology, profound expertise, and unwavering professionalism empowers the firm to deliver tailored sequencing solutions that meet every unique need.The magazine also features invaluable contributions from prominent industry leaders, including Carrie Lewis, executive director of clinical program optimisation at Endo International; Peter René Hesse, vice president and head of genomics business at QIAGEN; and Dr. Steven Henck, vice president of research and development at Integrated DNA Technologies. Their role in unravelling the intricacies of life at the genetic level is truly commendable, and we can anticipate exciting discoveries as a result of their ongoing contributions to the scientific community.We hope these valuable insights from industry leaders featured in this edition will assist you in making informed decisions for your businesses.Let us know your thoughts.EDITORIALEuropean Firms Leading Their Way in Sustainable Sanger Sequencing ServicesCopyright © 2023 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.Email:sales@lifesciencesreview.comeditor@lifesciencesreview.commarketing@lifesciencesreview.com NOVEMBER - 20 - 2023, Vol 04, Issue - 47 ( ISSN 2831-8331) Published by ValleyMedia, Inc.To subscribe to Life Sciences ReviewVisit www.lifesciencesreview.com Editorial StaffAaron PierceCarolynn WaltersShirley FaithRussell ThomasVisualizersDisclaimer: *Some of the Insights are based on our interviews with CIOs and CXOsJeremy WilliamsManaging Editoreditor@lifesciencesreview.comManaging EditorJeremy WilliamsClara MatthewCelestial Jordan
< Page 6 | Page 8 >